Fuslai
Overview
Suzhou Fushilai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials in China and internationally. The company offers lipoic acid products comprising granular alpha lipoic acid, R-lipoic acid, r-lipoic acid tromethamine salt, and 6,8-dichlorooctanoic acid ethyl ester; l-carnosine; phosphatidylcholine products, which include glyce
Employees540
Market Cap$2.3B
Revenue$412.5M
Listed OnShenzhen Stock Exchange
Ticker301258
CEOMr. Xiangyun Qian
HeadquartersChangshu